PatientSeek identifies a genetic signature that separates a4b7 integrin therapy responder and non-responder populations in inflammatory bowel disease
C4X Discovery Holdings Limited ...
| Ticker |
Sentiment |
Impact |
|
AZN
|
Somewhat Bullish
|
7 %
|
|
INDV
|
Somewhat Bullish
|
7 %
|
|
SNY
|
Somewhat Bullish
|
7 %
|
